Location History:
- Tampa, FL (US) (2011)
- Philadelphia, PA (US) (2013 - 2015)
Company Filing History:
Years Active: 2011-2015
Title: Innovations by Elizabeth Hood in Therapeutic Particle Targeting
Introduction
Elizabeth Hood is an accomplished inventor based in Philadelphia, PA, with a focus on advancements in therapeutic particle targeting. She holds three patents that showcase her innovative contributions to the field of drug delivery and medical technology. Her work emphasizes the importance of precision in targeting therapeutic agents to improve patient outcomes.
Latest Patents
One of her latest patents is titled "Uniform field magnetization and targeting of therapeutic formulations." This invention provides systems and methods for magnetic targeting of therapeutic particles, which include magnetic or magnetizable materials combined with therapeutic agents. The therapeutic particles can be specifically targeted using uniform magnetic fields, allowing for precise delivery to particular locations in the body. This technology also enables the capture, containment, and removal of these particles, which can include antioxidant enzymes aimed at protecting cells from oxidative damage.
Another significant patent is "Ultrasound enhancement of drug release across non-ionic surfactant membranes." This method utilizes nonionic surfactant vesicles, known as niosomes, in combination with ultrasound for targeted drug delivery and imaging. Niosomes are capable of encapsulating therapeutic agents and enhancing their uptake by physiological membranes. The invention demonstrates how ultrasound can non-invasively alter the niosome membrane structure, facilitating controlled release of compounds without compromising the niosome integrity.
Career Highlights
Elizabeth Hood has made substantial contributions to her field through her work at notable institutions such as the University of South Florida and The Children's Hospital of Philadelphia. Her research has focused on developing innovative methods for drug delivery that leverage both magnetic targeting and ultrasound technology.
Collaborations
Throughout her career, Elizabeth has collaborated with esteemed colleagues, including Joel A. Strom and Michael VanAuker. These partnerships have furthered her research and contributed to the advancement of therapeutic technologies.
Conclusion
Elizabeth Hood's innovative work in therapeutic particle targeting exemplifies the potential of combining advanced technologies to improve drug delivery systems. Her patents reflect a commitment to enhancing patient care through scientific innovation.